DuPont Board of Directors Approves the Separation of DuPont s Nutrition & Biosciences Business through an Exchange Offer
News provided by
Share this article
Share this article
WILMINGTON, Del., Dec. 18, 2020 /PRNewswire/ DuPont (NYSE: DD) today announced that its Board of Directors has approved the separation of DuPont s Nutrition & Biosciences business through an exchange offer (split-off) whereby DuPont stockholders can elect to tender shares of DuPont common stock in exchange for shares of Nutrition & Biosciences, Inc. ( N&B ) common stock. The separation will be followed by the simultaneous combination of N&B with International Flavors & Fragrances ( IFF ) in a Reverse Morris Trust transaction in which shares of N&B common stock will be converted into shares of IFF common stock.